The phage display technology that opened the door to Humira manufacturing was independently developed by three organizations, including the MRC Laboratory in the UK. The MRC went on to partner with some for-profit biotech/pharma companies to bring Humira to market.

The other two organizations that made their own phage display breakthroughs were the Scripps Research Institute (US nonprofit that gets a lot of government funding/grants) and the DKFZ (German national research organization, not sure about their funding but definitely not a typical pharma joint).

The big deal with Humira is that it's the first fully human monoclonal antibody to hit the shelves, and phage display is what made that possible.